9+ hour, 29+ min ago  (346+ words) The startup claims to have a "differentiated" antibody that can provide long-lasting protection against a variety of influenza strains. Biotechnology startup RQ Bio has snagged a nine-figure funding round to support development of a drug it believes to be capable…...

1+ day, 9+ hour ago  (280+ words) The setback dims the outlook for a medicine Pfizer sees as an important contributor going forward, though some analysts are optimistic about the drug's chances in another trial. A closely watched, experimental cancer drug Pfizer sees as a key revenue…...

2+ day, 11+ hour ago  (682+ words) A physician writing a prescription for a medication was once the defining moment of its success. But as specialty medicines play a growing role in healthcare, the patient journey that follows is just as critical to ensure optimal treatment outcomes…...

1+ day, 19+ hour ago  (506+ words) The biotech, co-founded by Sofinnova Partners and a former Sanofi immunology R&D head, is testing new biologics against common immune conditions. Bionyra, a biotechnology company building new biologics to treat immune diseases, emerged from stealth Monday with $165 million. Co-founded…...

5+ day, 21+ hour ago  (570+ words) The endorsement of an advisory committee positions Moderna to complete a dramatic turnaround for a shot the FDA declined to review earlier this year. Advisers to the Food and Drug Administration have thrown their support behind an experimental flu shot…...

1+ week, 8+ hour ago  (476+ words) The decision marks another regulatory U-turn following the exits of Marty Makary and Vinay Prasad, suggesting to some analysts that current FDA leadership may be more flexible in certain cases. Uni Qure, the Netherlands-based biotechnology company, intends to formally ask…...

1+ week, 9+ hour ago  (404+ words) Vedana Therapeutics emerged from stealth Wednesday with $46 million to support its mission of developing "anti-PACAP" therapies, an increasingly popular strategy for migraine prevention. An emerging area of drug development got more crowded Wednesday, with the debut of a biotechnology startup…...

1+ week, 1+ day ago  (572+ words) Ahead of a Thursday advisory panel meeting, agency scientists highlighted shortcomings in data accrued for a vaccine the FDA controversially refused to even review earlier this year. Food and Drug Administration scientists evaluating a potentially new messenger RNA flu vaccine…...

1+ week, 1+ day ago  (349+ words) Still, the results leave somewhat unclear how different the company's drug is than marketed hypertrophic cardiomyopathy medicines from Bristol Myers Squibb and Cytokinetics. Since Edgewise's executive team fully committed to the company's cardiovascular business, investor expectations ran high for the…...

1+ week, 2+ day ago  (381+ words) Acquired through its purchase of Ajax, the drug showed encouraging effects in patients with hard-to-treat'myelofibrosis. To analysts, such results could lead to competition for Incyte's Jakafi. An experimental drug that Eli Lilly recently picked up through a potentially multibillion-dollar acquisition…...